DIANA COOPER: Open Payments
NPI 1922649516 · ARCHDALE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 9 payments from 6 companies in 2025. Trend: 2023 $108 · 2024 $580 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $138 |
| ABBVIE INC. | 1 | $121 |
| Alkermes, Inc. | 2 | $102 |
| Teva Pharmaceuticals USA, Inc. | 1 | $101 |
| Neurocrine BioSciences, Inc. | 1 | $100 |
| Supernus Pharmaceuticals, Inc. | 2 | $96 |
Products named: FANAPT, VRAYLAR, AUSTEDO XR, INGREZZA, Qelbree, LYBALVI, ARISTADA, HETLIOZ.
Industry payments across NC — which companies pay providers there.
